Hold at 75% sub-benchmark defensive sizing; add only on confirmed technical reversal at $70.03
Patience position with defensive sizing. The business is high quality and cheap on absolute P/E with a real yield advantage, but the technical structure has not confirmed a base and Jackson Hole sits the day after. Let the 50 SMA flip from resistance to support before committing incremental capital, and let the dividend carry work at sub-benchmark defensive sizing until at least 3 of 5 medium-term confirmations fire. Upgrade triggers: confirmed daily close >$70.03 on volume >7M with MACD bullish cross AND RSI >55, OR on! segment disclosure showing 15%+ of revenue at next earnings, OR net debt below $21B with continued deleveraging. Downgrade triggers: daily close <$64.72 on volume >10M (200 SMA break), OR FDA menthol ban/nicotine cap announcement, OR guidance midpoint reduction, OR TTM FCF coverage falling below 1.0x, OR dividend cut warning. Full exit: daily close <$63.00 on volume >15M (capitulation), OR confirmed dividend cut, OR major FDA enforcement action that materially impairs pricing power.
| Position | Action |
|---|---|
| 1.5-2 of 5 medium-term confirmations at contested 200 SMA pivot with Jackson Hole overhang | Sub-benchmark defensive sizing at 75% of benchmark weight |
| Daily close below $64.72 on volume >10M (200 SMA break) | Trim 50% of position |
| Daily close below $63.00 on volume >15M (capitulation) | Full exit |
| Powell/Warsh signals cut and 10Y yields drop below 4.5% | Tactical trim of 25% of remaining position |
| Daily close above $70.03 on volume >7M with MACD bullish cross AND RSI >55 sustained | Add to position |
| Successful retest of $64.72-65.28 zone with stabilization, higher low, declining volume | Add to position |
MO is undervalued at 11.54x forward P/E (40% discount to market), with a 6.13% dividend yield that is structurally supported by 61.5% operating margins and 129% FCF/dividend coverage; HOLD is the wrong call when technical basing, raised guidance, and the PMI deal catalyst point to positive risk/reward.
| Indicator | Value | Signal |
|---|---|---|
| close_50_sma | 70.03 | bearish |
| close_200_sma | 64.72 | bullish |
| close_10_ema | 67.35 | neutral |
| rsi | 48.58 | neutral |
| macd | -0.69 | bearish |
| macds | -1.15 | bearish |
| macdh | +0.46 | bullish |
| boll | 66.82 | neutral |
| boll_ub | 70.04 | bearish |
| boll_lb | 63.61 | bullish |
| atr | 1.68 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Daily close above $70.03 on volume >7M with MACD bullish cross AND RSI >55 sustained
Then: Add to position
↩ rebuts: “Bear's medium-term 50 SMA cap warning”
· concedes: Waiting for pullback to 200 SMA at $64.72 means giving up the $3 premium and the dividend; price may not revisit that level; Tax inefficiency in taxable accounts is a valid placement concern (though not a thesis problem); The 50 SMA at ~$70.03 remains overhead resistance; U.S. cigarette volume decline at ~4–5% per year is real and acknowledged
MO is a yield trap wrapped in a value coat — structurally declining due to 4–5%/year volume decline, binary regulatory risk, and a deteriorating technical setup, with the 6.13% dividend exposed to multiple tail risks that make the risk/reward asymmetrically negative.
EV: -2.3% · concedes: The 6.13% dividend is safe in the base case; The 11.54x forward P/E is technically a discount to the S&P 500; Some technical indicators (MACD histogram turning positive, Bollinger squeeze) show short-term volatility contraction
→ vs conservative: Waiting for volume-confirmed close above 70.03 with RSI above 55 is market timing perfection theater that will result in chasing the stock higher after missing the initial move
→ vs conservative: Stop at 64.72 with target of 74 gives better than 2-to-1 reward-to-risk ratio on a defensive name with 0.495 beta, plus 6% annual yield while waiting
→ vs conservative: Q2 EPS miss is already in the rearview mirror and priced in; raised guidance floor is the forward-looking signal that matters
→ vs conservative: NJOY 1.16 billion impairment was taken in 2025 - continuing to price it as forward risk is anchoring on stale information
→ vs conservative: Hard stop at 62.50 for future adds requires 8% drop before engaging - this is paralysis dressed up as discipline
→ vs neutral: MACD histogram positive for three straight sessions and climbing - momentum already turning despite falling 50 SMA lagging
→ vs neutral: Price now 1.57 above VWMA after weeks below it; ATR compressing from 2.24 to 1.68; distribution phase has clearly ended
→ vs neutral: By the time 50 SMA flattens and turns up, stock will be at 72 not 67 - waiting for lagging indicator confirmation means missing the move
→ vs neutral: Jackson Hole on August 28 is a nothingburger for MO - hawkish surprise validates yield story, dovish surprise compresses bond yields making MO relatively more attractive
→ vs conservative: PMI manufacturing deal first shipments in 2027 gives narrative a 12-month runway of optimism; 42% probability of acquisition catalyst could gap stock to 73-75 overnight
| vwma | 66.10 | bullish |
Support: 63.96 · 64.72 | Resistance: 70 · 70.18 · 74.92
MO is base-building after an August air-pocket gap-down event (67.94 on 2026-07-30 on 3.6× average volume), with structural uptrend intact but medium-term 50 SMA rolling over and capping rallies; RSI neutralized to 48.58 from oversold lows, MACD histogram flipping positive for 3 sessions suggesting early bullish divergence, Bollinger bands squeezing (UB rolling down 76.67→70.04, LB rising 61.59→63.61), and VWMA suggesting distribution ending/accumulation beginning. Key triggers: bullish entry requires daily close > 70.03 with RSI > 55; bearish exit below 63.96. Final rating: HOLD.
Market Cap
$112.99B
Trailing P/E
14.25x
Forward P/E
11.54x
PEG Ratio
2.68
Price/Book
-42.35x
EPS (TTM)
$4.75
Forward EPS
$5.86
Dividend Yield
6.13%
Beta
0.495
52-Week High
$77.06
52-Week Low
$54.70
50-Day Avg
$70.08
200-Day Avg
$66.01
TTM Revenue
$20.44B
TTM EBITDA
$15.77B
Operating Margin
61.5%
Profit Margin
39.0%
ROA
29.5%
TTM FCF
$9.04B
Annual Dividends
~$7.0B
Annual Buybacks
~$1.0B
Total Debt
$24.58B
Net Debt
$22.21B
Cash & Equivalents
$2.37B
Net Debt / EBITDA
~1.4x
Stockholders' Equity
($2,668M)
Treasury Stock
$43,505M
Current Ratio
0.52
2025 Total Revenue
$20,139M
2024 Total Revenue
$20,444M
2023 Total Revenue
$20,502M
2022 Total Revenue
$20,688M
2025 Net Income
$6,947M
2024 Net Income
$11,264M
2025 Diluted EPS
$4.12
2024 Diluted EPS
$6.54
2023 Diluted EPS
$4.57
2022 Diluted EPS
$3.19
Normalized EBITDA
$12.3–$13.0B
Effective Tax Rate (2024)
17.5%
Effective Tax Rate (2025)
~26%
2025 CapEx
$216M
2024 CapEx
$142M
Diluted Shares Outstanding
1.670B
Diluted Shares Outstanding
1.683B
Diluted Shares Outstanding
1.804B
Strengths
Concerns
Altria Group (MO) is a high-quality, defensive income stock with strong free cash flow generation ($9B+ annually), industry-leading 61.5% operating margins, and a reliable 6.13% dividend yield backed by >100% FCF/dividend coverage. The company faces secular headwinds from declining cigarette volumes (~4–5%/year) and regulatory/litigation risks, but normalized earnings power is stable at ~$9B/year ($5.20–$5.50 EPS) after stripping out one-time items. The stock is rated HOLD — appropriate for income/defensive portfolios — but near 52-week highs provide limited near-term upside; a pullback to the 200-day moving average (~$66) would offer a more attractive entry for fresh positions.
Macro: Federal Reserve holds rates through 2026 (88% Polymarket consensus); 10-year Treasury yields above 4.7%; US recession probability at 8% (end-2026); consumer staples underperforming cyclicals (-4.8% vs. S&P +10.5% over 6 months) but MO has bucked the trend; Jackson Hole speech by Fed Chair Warsh scheduled for August 28, 2026.